These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 913601)

  • 81. Vasoactive intestinal polypeptide and glucagon: stimulation of adenylate cyclase activity via distinct receptors in liver and fat cell membranes.
    Desbuguois B; Laudat MH; Laudat P
    Biochem Biophys Res Commun; 1973 Aug; 53(4):1187-94. PubMed ID: 4356054
    [No Abstract]   [Full Text] [Related]  

  • 82. Effect of DDT on adenylate cyclase activity in rat liver cell membranes.
    Pöschl E; Buff K; Berndt J
    Chem Biol Interact; 1982 Apr; 39(3):369-74. PubMed ID: 6280883
    [No Abstract]   [Full Text] [Related]  

  • 83. N6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes.
    Wallace AV; Heyworth CM; Houslay MD
    Biochem J; 1984 Aug; 222(1):177-82. PubMed ID: 6089755
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The activation of adenylate cyclase. II. The postulated presence of (A) adenylate cyclase in a phospho (inhibited) form (B) a dephospho (activated) form with a cyclic adenylate stimulated membrane protein kinase.
    Constantopoulos A; Najjar VA
    Biochem Biophys Res Commun; 1973 Aug; 53(3):794-9. PubMed ID: 4354448
    [No Abstract]   [Full Text] [Related]  

  • 85. Phospholipase C digestion of rat liver plasma membrane stimulates adenylate cyclase.
    Nemecz G; Farkas T; Horváth LI
    Arch Biochem Biophys; 1981 Apr; 207(2):256-63. PubMed ID: 7247403
    [No Abstract]   [Full Text] [Related]  

  • 86. Lysophosphatidylcholines can modulate the activity of the glucagon-stimulated adenylate cyclase from rat liver plasma membranes.
    Houslay MD; Palmer RW
    Biochem J; 1979 Jan; 178(1):217-21. PubMed ID: 435279
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Inhibition of the glucagon stimulated adenylate cyclase activity by insulin.
    Kiss Z
    FEBS Lett; 1978 Aug; 92(1):29-32. PubMed ID: 668918
    [No Abstract]   [Full Text] [Related]  

  • 88. Inhibitors of glucagon inactivation. Effect on glucagon--receptor interactions and glucagon-stimulated adenylate cyclase activity in liver cell membranes.
    Desbuquois B; Krug F; Cuatrecasas P
    Biochim Biophys Acta; 1974 Mar; 343(1):101-20. PubMed ID: 4364124
    [No Abstract]   [Full Text] [Related]  

  • 89. Challenge of hepatocytes by glucagon triggers a rapid modulation of adenylate cyclase activity in isolated membranes.
    Heyworth CM; Houslay MD
    Biochem J; 1983 Jul; 214(1):93-8. PubMed ID: 6615475
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The activation of adenylate cyclase. I. A postulated mechanism for fluoride and hormone activation of adenylate cyclase.
    Najjar VA; Constantopoulos A
    Mol Cell Biochem; 1973 Nov; 2(1):87-93. PubMed ID: 4764472
    [No Abstract]   [Full Text] [Related]  

  • 91. Glucagon structure and function. II. Increased activity of iodoglucagon.
    Bromer WW; Boucher ME; Patterson JM
    Biochem Biophys Res Commun; 1973 Jul; 53(1):134-9. PubMed ID: 4741542
    [No Abstract]   [Full Text] [Related]  

  • 92. Alterations in plasma membrane proteins associated with the proteolytic activation of adenylate cyclase.
    Pinkett MO; Anderson WB
    Arch Biochem Biophys; 1980 Mar; 200(1):261-8. PubMed ID: 7362256
    [No Abstract]   [Full Text] [Related]  

  • 93. Partial purification and characterization of a macromolecule which enhances fluoride activation of adenylate cyclase.
    Rasenick MM; Bitensky MW
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4628-32. PubMed ID: 6933510
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Comparison of the epinephrine-mediated activation of adenylate cyclase in plasma membranes from liver and ascites hepatomas of rats.
    Okamura N; Terayama H
    Biochim Biophys Acta; 1976 Dec; 455(2):297-314. PubMed ID: 187240
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cytosolic activator of adenylate cyclase: Reconstitution, characterization, and mechanism of action.
    Sahyoun N; LeVine H; Stenbuck P; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3646-50. PubMed ID: 6574502
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Synthesis and isolation of a glucagon antagonist.
    Bregman MD; Hruby VJ
    FEBS Lett; 1979 May; 101(1):191-4. PubMed ID: 446735
    [No Abstract]   [Full Text] [Related]  

  • 97. Enrichment of glucagon sensitive adenyl cyclase upon preparation of parenchymal cells from rat liver.
    Christoffersen T; Morland J; Osnes JB; Berg T; Boman D; Seglen PO
    Arch Biochem Biophys; 1972 Jun; 150(2):807-9. PubMed ID: 5044053
    [No Abstract]   [Full Text] [Related]  

  • 98. Detergent dispersion of adenylate cyclase from partially purified rat liver plasma membranes.
    Pilkis SJ; Johnson RA
    Biochim Biophys Acta; 1974 Apr; 341(2):388-95. PubMed ID: 4365088
    [No Abstract]   [Full Text] [Related]  

  • 99. Alterations in hormone responsiveness of hepatic adenylate cyclase during ontogenesis and oncogenesis.
    Christoffersen T; Oye I
    Acta Endocrinol Suppl (Copenh); 1974; 191():67-71. PubMed ID: 4375382
    [No Abstract]   [Full Text] [Related]  

  • 100. Characteristics of glucagon action on the hepatic adenylate cyclase system.
    Rodbell M; Birnbaumer L; Pohl SL
    Biochem J; 1971 Dec; 125(3):58P-59P. PubMed ID: 5145874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.